Showing results 1 to 20 of 33
next >
| Issue Date | Title | Author(s) |
| 2023 | Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China | Hua, Rui; Kong, Fei; Li, Guangming; Wen, Xiaofeng; Zhang, Yuexin; Yang, Xingxiang; Meng, Chenxin; Xie, Wen; Jiang, Yongfang; Wang, Xiaozhong; Han, Xueji; Huang, Yan; Mao, Qing; Wang, Jiefei; Guan, Yujuan; Chen, Jiayu; Ma, Yingjie; Xiong, Qingfang; Ma, Hong; Yan, Xuebing; Rao, Huiying; Zhao, Yingren; Sun, Tong; Zhu, Liying; Mao, Xiaorong; Lian, Jianqi; Deng, Guojiong; Xin, Yongning; Wang, Yifei; Ye, Yinong; Xu, Bin; Gao, Hainv; Tan, Youwen; Li, Dongliang; Yang, Dongliang; Su, Minghua; Zhang, Xiaomeng; Min, Jie; Shi, Xinsheng; Wei, Lai; Niu, Junqi |
| 2019 | Chinese guidelines on management of hepatic encephalopathy in cirrhosis | Xu, Xiao-Yuan; Ding, Hui-Guo; Li, Wen-Gang; Jia, Ji-Dong; Wei, Lai; Duan, Zhong-Ping; Liu, Yu-Lan; Ling-Hu, En-Qiang; Zhuang, Hui; An, Ji-Hong; Cai, Da-Chuan; Chen, Guo-Feng; Chen, Hong-Song; Chen, Jing-Long; Chen, Yu; Cheng, Jun; Dou, Xiao-Guang; Feng, Zhi-Jie; Gao, Hui; Gao, Yan-Hang; Geng, Jia-Wei; Guo, Hui-Min; Guo, Wu-Hua; Han, Tao; Han, Ying; Huang, Yuan; Jiang, Jian-Ning; Jiang, Ying-An; Kong, Yuan-Yuan; Li, Cang-You; Li, Guang-Ming; Li, Jie; Li, Shu-Chen; Li, Tai-Sheng; Li, Yu-Fang; Liu, Jing-Feng; Liu, Xiao-Qing; Liu, Ying-Di; Lu, Lun-Gen; Luo, Xin-Hua; Ma, An-Lin; Ma, Xiong; Mao, Qing; Mao, Yi-Min; Nan, Yue-Min; Nie, Yu-Qiang; Ren, Hong; Ren, Wan-Hua; Shang, Jia; Wang, Lei; Wang, Yu-Ming; Wang, Xiao-Jun; Wu, Jing; Xie, Wei-Fen; Xie, Wen; Xin, Shao-Jie; Xing, Hui-Chun; Xu, Jian-Ming; Xu, Jie; Xu, Jing-Hang; Xu, You-Qing; Yan, Ming; Yang, Dong-Liang; Yang, Ji-Ming; Yang, Jin-Hui; Yang, Yong-Feng; Yang, Yong-Ping; You, Hong; Yu, Yan-Yan; Zhai, Suo-Di; Zhang, Chun-Qing; Zhang, Da-Zhi; Zhang, Ling-Yi; Zhang, Lun-Li; Zhang, Wen-Hong; Zhao, Jing-Min; Zhao, Ping; Zhao, Shou-Song; Zhu, Xuan; Zuo, Wei-Ze; Kang, Qian; Luo, Hao; Tan, Ning |
| 2014 | Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection | Rao, Huiying; Wei, Lai; Carlos Lopez-Talavera, Juan; Shang, Jia; Chen, Hong; Li, Jun; Xie, Qing; Gao, Zhiliang; Wang, Lei; Wei, Jia; Jiang, Jianning; Sun, Yongtao; Yang, Ruifeng; Li, Hong; Zhang, Haiying; Gong, Zuojiong; Zhang, Lunli; Zhao, Longfeng; Dou, Xiaoguang; Niu, Junqi; You, Hong; Chen, Zhi; Ning, Qin; Gong, Guozhong; Wu, Shuhuan; Ji, Wei; Mao, Qing; Tang, Hong; Li, Shuchen; Wei, Shaofeng; Sun, Jian; Jiang, Jiaji; Lu, Lungen; Jia, Jidong; Zhuang, Hui |
| 10-Feb-2021 | Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial | Shi, Lei; Huang, Hai; Lu, Xuechun; Yan, Xiaoyan; Jiang, Xiaojing; Xu, Ruonan; Wang, Siyu; Zhang, Chao; Yuan, Xin; Xu, Zhe; Huang, Lei; Fu, Jun-Liang; Li, Yuanyuan; Zhang, Yu; Yao, Wei-Qi; Liu, Tianyi; Song, Jinwen; Sun, Liangliang; Yang, Fan; Zhang, Xin; Zhang, Bo; Shi, Ming; Meng, Fanping; Song, Yanning; Yu, Yongpei; Wen, Jiqiu; Li, Qi; Mao, Qing; Maeurer, Markus; Zumla, Alimuddin; Yao, Chen; Xie, Wei-Fen; Wang, Fu-Sheng |
| 2012 | Effects of monomer structure on the morphology of polymer networks and the electro-optical properties of polymer-dispersed liquid crystal films | Liu, Fang; Cao, Hui; Mao, Qing; Song, Ping; Yang, Huai |
| Jan-2022 | Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial | Wei, Lai; Zhao, Tingting; Zhang, Ji; Mao, Qing; Gong, Guozhong; Sun, Yongtao; Chen, Yongping; Wang, Maorong; Tan, Deming; Gong, Zuojiong; Li, Baosen; Niu, Junqi; Li, Shuchen; Gong, Huanyu; Zou, Liyun; Zhou, Wei; Jia, Zhengcai; Tang, Yan; Fei, Lei; Hu, Yang; Shang, Xiaoyun; Han, Junfeng; Zhang, Bei; Wu, Yuzhang |
| 2012 | Entecavir maleate versus Entecavir in Chinese patients with HBeAg-Positive Chronic Hepatitis B: Results at 48 and 96 weeks of a Randomized Double-blind Multicenter Clinical Trial | Yu, Yanyan; Xu, Jinghang; Tang, Hong; Zhang, Dazhi; Mao, Qing; Li, Jun; Xu, Zhongnan; Zhang, Xiquan; Dai, Jun; Si, Chongwen |
| 2014 | High Response Rate and Good Tolerability of Genotype 6 Chronic Hepatitis C Patients to Pegylated Interferon alfa combining Ribavirin in China | Wei, Lai; Gao, ZhiLiang; Mao, Qing; Zhang, Dazhi; Jiang, Jianning; Gong, Guozhong; Yin, Zhibiao; Xie, Qing; Sun, Jian; Rao, Huiying; Feng, Bo; Yang, Ruifeng; Zhang, Haiying |
| 2019 | Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results | Liang, Xieer; Gao, Zhiliang; Xie, Qing; Zhang, Jiming; Sheng, Jifang; Cheng, Jun; Chen, Chengwei; Mao, Qing; Zhao, Wei; Ren, Hong; Tan, Deming; Niu, Junqi; Chen, Shijun; Pan, Chen; Tang, Hong; Wang, Hao; Mao, Yimin; Jia, Jidong; Ning, Qin; Xu, Min; Wu, Shanming; Li, Jun; Zhang, Xinxin; Zhang, Wenyan; Xiong, Cui; Hou, Jinlin |
| Nov-2020 | LONG-TERM FOLLOW-UP OF PEGINTERFERON ALFA TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS IN PHASE III STUDY OF PEGINTERFERON ALFA-2b (40kD, Y SHAPE) (PEGBERON): A 4-YEAR FOLLOW-UP REPORT | Wang, Guiqiang; Hou, Fengqin; Zhang, Min; Shang, Jia; Pan, Chen; Lv, Hui; Zhang, Mingxiang; Peng, Yanzhong; Xie, Qing; Wang, Maorong; Zhang, Dazhi; Chen, Yongping; Mao, Qianguo; Liu, Jiajun; Peng, Jie; Mao, Qing; Yang, Yongfeng; Yin, Chibiao; Han, Tao; Cheng, Na; Zhen, Zhen; Zhang, Jiming; Tan, Deming; Chen, Liang; Meng, Qinghua; Wang, Hao; Chen, Chengwei; Li, Baosen; Chen, Jun; Yin, Yalin; Sun, Li |
| 2017 | Long-term follow-up of peginterferon alpha treatment of HBeAg-positive chronic hepatitis B patients in phase III study of peginterferon alpha-2b (40kD, Y Shape) (Pegberon) | Hou, Fengqin; Shang, Jia; Zhang, Mingxiang; Pan, Chen; Peng, Yan-zhong; Chen, Shijun; Zhang, Dazhi; Zhao, Wei; Mao, Qian-guo; Mao, Qing; Chen, Yongping; Wang, Maorong; Yin, Chibiao; Peng, Jie; Wang, Hao; Meng, Qinghua; Tan, Deming; Sun, Li; Wang, Guiqiang |
| 2017 | Long-term follow-up of peginterferon alpha treatment of HBeAg-positive chronic hepatitis B patients in phase III study of peginterferon alpha-2b (40kD, Y Shape) (Pegberon) | Hou, Fengqin; Shang, Jia; Zhang, Mingxiang; Pan, Chen; Peng, Yan-zhong; Chen, Shijun; Zhang, Dazhi; Zhao, Wei; Mao, Qian-guo; Mao, Qing; Chen, Yongping; Wang, Maorong; Yin, Chibiao; Peng, Jie; Wang, Hao; Meng, Qinghua; Tan, Deming; Sun, Li; Wang, Guiqiang |
| 2018 | Long-Term Follow-up of Peginterferon alpha-2b (40kD, Y Shape) (Pegberon) Treatment of Hbeag-Positive Chronic Hepatitis B Patients in Phase III Study | Wang, Guiqiang; Hou, Fengqin; Zhang, Mingxiang; Zhang, Dazhi; Peng, Yanzhong; Shang, Jia; Chen, Shijun; Gong, Guozhong; Chen, Yongping; Wang, Maorong; Pan, Chen; Xie, Qing; Zhao, Wei; Liu, Jiajun; Peng, Jie; Mao, Qing; Yin, Chibiao; Zhang, Jiming; Zhen, Zhen; Chen, Liang; Tan, Deming; Wang, Hao; Mao, Qianguo; Meng, Qinghua; Chen, Chengwei; Sun, Li |
| 2018 | Long-Term Follow-up of Peginterferon alpha-2b (40kD, Y Shape) (Pegberon) Treatment of Hbeag-Positive Chronic Hepatitis B Patients in Phase III Study | Wang, Guiqiang; Hou, Fengqin; Zhang, Mingxiang; Zhang, Dazhi; Peng, Yanzhong; Shang, Jia; Chen, Shijun; Gong, Guozhong; Chen, Yongping; Wang, Maorong; Pan, Chen; Xie, Qing; Zhao, Wei; Liu, Jiajun; Peng, Jie; Mao, Qing; Yin, Chibiao; Zhang, Jiming; Zhen, Zhen; Chen, Liang; Tan, Deming; Wang, Hao; Mao, Qianguo; Meng, Qinghua; Chen, Chengwei; Sun, Li |
| 2019 | Management Algorithm for Interrupting Mother-to-Child Transmission of Hepatitis B Virus | Hou, Jinlin; Cui, Fuqiang; Ding, Yang; Dou, Xiaoguang; Duan, Zhongping; Han, Guorong; Jia, Jidong; Mao, Qing; Li, Jie; Li, Zengde; Liu, Zhihua; Wei, Lai; Xie, Qing; Yang, Xizhong; Zhang, Hua; Zhuang, Hui |
| Jun-2022 | Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022) | Liu, Zhihua; Chen, Zhongdan; Cui, Fuqiang; Ding, Yang; Gao, Yunfei; Han, Guorong; Jia, Jidong; Li, Jie; Li, Zengde; Liu, Yingxia; Mao, Qing; Wang, Ailing; Wang, Wei; Wei, Lai; Xia, Jianhong; Xie, Qing; Yang, Xizhong; Yin, Xueru; Zhang, Hua; Zhang, Liaoyun; Zhang, Wenhong; Zhuang, Hui; Dou, Xiaoguang; Hou, Jinlin |
| 2018 | On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy | Wei, Lai; Shang, Jia; Xie, Qing; Jia, Zhansheng; Gao, Pujun; Shi, Junping; Chen, Xinyue; Wang, Jiefei; Xu, Min; Zhang, Liaoyun; Zhao, Yingren; Wang, Maorong; Mao, Qing; Zhao, Wei; Zhang, Zong; Jia, Jidong; Tang, Hong; Zhang, Jiming; Zheng, Xin; Xiong, Cui; Zhu, Mingfen |
| 2018 | On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy | Wei, Lai; Shang, Jia; Xie, Qing; Jia, Zhansheng; Gao, Pujun; Shi, Junping; Chen, Xinyue; Wang, Jiefei; Xu, Min; Zhang, Liaoyun; Zhao, Yingren; Wang, Maorong; Mao, Qing; Zhao, Wei; Zhang, Zong; Jia, Jidong; Tang, Hong; Zhang, Jiming; Zheng, Xin; Xiong, Cui; Zhu, Mingfen |
| 2017 | Phase II b trial of in vivo electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy | Yang, Fu-Qiang; Rao, Gui-Rong; Wang, Gui-Qiang; Li, Yue-Qi; Xie, Yao; Zhang, Zhan-Qing; Deng, Cun-Liang; Mao, Qing; Li, Jun; Zhao, Wei; Wang, Mao-Rong; Han, Tao; Chen, Shi-Jun; Pan, Chen; Tan, De-Ming; Shang, Jia; Zhang, Ming-Xiang; Zhang, Yue-Xin; Yang, Ji-Ming; Chen, Guang-Ming |
| Sep-2021 | Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 Trial | Gao, Yanhang; Kong, Fei; Song, Xinwen; Shang, Jia; Yao, Lvfeng; Xia, Jinyu; Peng, Yanzhong; Liu, Weidong; Gong, Huanyu; Mu, Mao; Cui, Hesong; Han, Tao; Chen, Wen; Wu, Xiaolu; Yang, Yongfeng; Yan, Xuebing; Jin, Zhenjing; Wang, Peng; Zhu, Qingjing; Chen, Liang; Zhao, Caiyan; Zhang, Dengke; Jin, Weili; Wang, Daidi; Wen, Xiuhong; Liu, Chunmei; Jia, Jidong; Mao, Qing; Ding, Yanhua; Jin, Xueyuan; Zhang, Zong; Mao, Qianguo; Li, Guangming; Niu, Junqi |
